1. Home
  2. Clinical Topics
  3. Potential new treatment for SRI-resistant patients with depression
Clinical TopicsDepressionDrugs and DevicesHealthcare & TechnologyMental HealthWeb Exclusives

Potential new treatment for SRI-resistant patients with depression

Share

S-adenosyl methionine (SAMe), a naturally occurring molecule, may be an effective treatment for patients with depression who don’t respond to serotonin reuptake inhibitors (SRIs) according to a study of 73 patients in the American Journal of Psychiatry. Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts